title: [Tanakan in the treatment of cognitive and autonomic impairments and headache in young patients].
abstract: OBJECTIVE
  To determine the efficacy and tolerability of tanakan in the treatment of memory and attention impairments in young patients.
  
  
  METHODS
  We studied 30 outpatients (24 women and 6 men, mean age 33,5±7,5 years) with headache, memory and attention impairments and decrease in mental working capacity. Treatment duration was 90 days. Patients received tanakan in dose 40 mg 3 times per day to restore cognitive function. The study design included 4 visits during which patients completed questionnaires and scales.
  
  
  RESULTS
  All patients reported positive changes in mood, memory, information learning and working capacity. Headaches of tension decreased by 50%, vertigo and noise in ears became less intense, autonomic disturbances practically disappeared. No effect on the frequency of migrainous attacks was found.
  
  
  CONCLUSIONS
  Tanakan is effective and safe for symptomatic therapy of cognitive impairment in any age, including young patients.
authors.forename: M V
authors.initials: MV
authors.lastname: Naprienko
mesh_terms: D000328:Adult; D001288:Attention; D001342:Autonomic Nervous System Diseases / Q000188:drug therapy*; D003072:Cognition Disorders / Q000188:drug therapy*; D005260:Female; D020441:Ginkgo biloba; D020773:Headache Disorders / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000188:drug therapy*; D010936:Plant Extracts / Q000627:therapeutic use*; D000096983:Ginkgo Extract
chemical_list: D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract